|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL STUDY |
ak Podkraj
ek1
2
51 Centre for Medical Genetics, University Medical Centre, University Children's Hospital, Vrazov trg 1, SI-1000 Ljubljana, Slovenia2 Mother and Child Health Care Institute of Serbia, Belgrade, Serbia3 Department of Pediatrics, Catharina Ziekenhuis, Eindhoven, The Netherlands4 Department of Metabolic and Endocrine Disease, University Medical Center St Radboud, Nijmegen, The Netherlands5 Department of Pediatric Endocrinology, Diabetes and Metabolism, University Medical Centre, University Children's Hospital, Ljubljana, Slovenia
(Correspondence should be addressed to K T Podkraj
ek; Email: katarina.trebusak{at}kclj.si)
Objective: Autoimmune polyglandular syndrome type 1 (APS-1) is characterised by multiple autoimmune diseases. Detection of autoimmune regulator (AIRE) gene mutations facilitates timely and precise diagnosis.
Design: AIRE mutation detection was performed in a cohort of 11 patients. Two did not meet clinical APS-1 criteria and several started with atypical presentation.
Methods: Sequencing and TaqMan genotyping were used to identify AIRE mutations. Complete AIRE deletion was confirmed and framed by real-time PCR, long-range amplification and analysis of the microsatellite markers.
Results: Seven different mutations were detected, three were novel: c.892G>A in exon 8, silent mutation c.462A>T in exon 3 most likely affecting splicing, and a complete deletion of a single AIRE allele ((?_68)_(1567-14_?)del). Novel (chronic otitis) and rare (systemic juvenile rheumatoid arthritis, autoimmune bronchiolitis, epilepsy) clinical presentations were observed.
Conclusions: AIRE mutation detection was valuable in the diagnostics of APS-1 in patients with atypical presentation. Chronic otitis media possibly broadened the cluster of APS-1 manifestations.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |